Latest PEG ratio for XOMA Royalty: 27.47 — see history and peer comparisons.
Get informed when a big investor buys or sells
+ Follow27.47
The PEG ratio measures a stock's valuation relative to its earnings growth rate. A PEG ratio below 1.0 may indicate that the stock is undervalued relative to its growth potential.
XOMA Royalty's peg ratio stands at 27.47. That is above the Healthcare sector average of 1.18. Stockcircle updates this page with the newest filings so you can track how the metric evolves quarter by quarter.
XOMA Royalty sits higher the Healthcare benchmark (1.18) with a PEG ratio of 27.47. That is roughly 2218.6% above the sector mean. Peer context matters because what looks expensive or cheap in absolute terms can be normal for the sector.
Whether 27.47 is attractive depends on XOMA Royalty's earnings outlook, competitive position, and how peers are valued. Investors typically ask: is growth accelerating, are margins stable, and is the multiple expanding or compressing over time? The history and comparison charts below are built for those checks.
The history chart shows how XOMA Royalty's PEG ratio evolved across reporting periods, while the comparison chart places XOMA next to similar companies. Use both: a rising metric that still lags peers tells a different story than a rising metric that already leads the group. Growth charts, when available, highlight acceleration or slowdown.
Yes — within Healthcare, PEG ratio is commonly used to spot outliers. XOMA Royalty's reading of 27.47 (sector avg 1.18) is a starting point; confirm whether differences come from growth, margins, accounting choices, or one-time items before treating an outlier as a buy or sell signal.